The Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC) is a clinical trials network of adult and paediatric endocrinologists, immunologists, clinical triallists and members of the type 1 diabetes (T1D) community across Australia and New Zealand.
Working together, we are accelerating development and delivery of immunotherapy treatments for people with type 1 diabetes.

Page last updated: 8 August 2022